Reporting on 2009 surveillance data and 2010 epidemic intelligence data

In 2016, 29 EU/EEA countries reported 12 502 cases of hepatitis A, of which 12 429 (99.4%) were confirmed.

In 2017, 30 EU/EEA Member States reported 26 907 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 26 262, corresponds to a crude rate of 6.7 cases per 100 000 population.

In 2017, 31 273 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases, 31 178 cases corresponds to a crude rate of 7.3 cases per 100 000 population.

In 2015, 34 651 cases of hepatitis C were reported from 28 EU/EEA Member States, a crude rate of 8.6 per 100 000 population. Of the cases reported, 1.0% were classified as acute, 12.7% as chronic, 69.5% as ‘unknown’ and 16.8% were not classified.

In 2016, 33 860 cases of hepatitis C were reported in 29 EU/EEA Member States, corresponding to a crude rate of 7.4 cases per 100 000 population.

In 2016, 30 EU/EEA Member States reported 29 307 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 5.5 cases per 100 000 population.

In 2015, 30 EU/EEA Member States reported 24 573 cases of hepatitis B virus (HBV) infection, a crude rate of 4.7 cases per 100 000 population.

In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed.

In 2014, 13 724 cases of hepatitis A (13 678 of which were confirmed) were reported in EU/EEA countries.